# China Pharma Holdings Inc. (CPHI)

Source: https://www.quantisnow.com/company/CPHI
Generated: 2026-11-22T11:11:53.584Z

- Ticker: CPHI
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001106644
- Website: chinapharmaholdings.com

## About

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.

## Latest CPHI news and filings

- 2026-11-18 21:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-6798723)
- 2026-11-17 19:45 UTC [SEC Form NT 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-china-pharma-holdings-inc-6796345)
- 2026-11-10 21:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-china-pharma-holdings-inc-6783927)
- 2026-10-30 20:40 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-china-pharma-holdings-inc-6765457)
- 2026-08-14 20:32 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-6683322)
- 2026-07-23 22:49 UTC [Public Offering] [China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering](https://www.quantisnow.com/insight/china-pharma-holdings-inc-announces-closing-of-50-million-registered-6647609)
- 2026-07-23 10:07 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-pharma-holdings-inc-6646016)
- 2026-07-22 21:26 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-entry-into-6645750)
- 2026-07-22 13:25 UTC [Public Offering] [China Pharma Announces Pricing of $5 Million Registered Direct Offering](https://www.quantisnow.com/insight/china-pharma-announces-pricing-of-5-million-registered-direct-offering-6644886)
- 2026-07-21 20:00 UTC [China Pharma Holdings, Inc. Comments on Unusual Market Activity](https://www.quantisnow.com/insight/china-pharma-holdings-inc-comments-on-unusual-market-activity-6643707)
- 2026-07-15 16:12 UTC [China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity](https://www.quantisnow.com/insight/china-pharma-holdings-inc-states-it-knows-of-no-events-6638047)
- 2026-05-15 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-6557186)
- 2026-05-14 12:56 UTC [China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity](https://www.quantisnow.com/insight/china-pharma-holdings-inc-states-it-knows-of-no-events-6552755)
- 2026-04-01 20:15 UTC [SEC Form 10-K] [SEC Form 10-K filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-china-pharma-holdings-inc-6482037)
- 2026-04-01 20:05 UTC [SEC Form NT 10-K filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-china-pharma-holdings-inc-6481803)
- 2026-03-03 21:05 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-entry-into-6424969)
- 2026-02-10 21:49 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-entry-into-6384633)
- 2026-01-06 21:05 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-submission-of-6338310)
- 2025-12-23 21:05 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-entry-into-6326703)
- 2025-12-10 21:49 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-entry-into-6310907)
- 2025-11-14 21:22 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-china-pharma-holdings-inc-6280790)
- 2025-11-12 21:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-6274525)
- 2025-11-04 21:05 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-china-pharma-holdings-inc-6259098)
- 2025-08-14 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-6166068)
- 2025-05-14 20:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-6039231)
- 2025-04-04 20:05 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-regulation-fd-5977824)
- 2025-04-04 20:05 UTC [China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split](https://www.quantisnow.com/insight/china-pharma-holdings-inc-announces-1-for-10-reverse-stock-split-5977796)
- 2025-03-31 20:20 UTC [SEC Form 10-K] [SEC Form 10-K filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-china-pharma-holdings-inc-5967299)
- 2024-12-26 21:30 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-termination-of-5825214)
- 2024-12-26 21:05 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-submission-of-5825067)
- 2024-12-18 13:30 UTC [China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville](https://www.quantisnow.com/insight/china-pharma-holdings-inc-completes-full-redemptions-under-convertible-note-5818211)
- 2024-12-13 13:20 UTC [SEC Form 8-K] [China Pharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/china-pharma-holdings-inc-filed-sec-form-8-k-entry-into-5812343)
- 2024-12-13 13:15 UTC [SEC Form 424B5] [SEC Form 424B5 filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-china-pharma-holdings-inc-5812330)
- 2024-12-13 13:00 UTC [China Pharma Announces the Entry of "At-The-Market" Equity Offering](https://www.quantisnow.com/insight/china-pharma-announces-the-entry-of-at-the-market-equity-offering-5812286)
- 2024-11-13 21:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-5771321)
- 2024-11-12 21:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-china-pharma-holdings-inc-5767422)
- 2024-11-01 20:05 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-china-pharma-holdings-inc-5748231)
- 2024-08-19 12:00 UTC [China Pharma Holdings, Inc.  expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025](https://www.quantisnow.com/insight/china-pharma-holdings-inc-expects-to-launch-its-dry-eye-5663771)
- 2024-08-14 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by China Pharma Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-china-pharma-holdings-inc-5659040)
- 2024-06-17 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-5562362)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CPHI
- Earnings history: https://www.quantisnow.com/earnings/CPHI
- Dividend history: https://www.quantisnow.com/dividends/CPHI
- Insider transactions: https://www.quantisnow.com/insiders/CPHI
- Options chain: https://www.quantisnow.com/options/CPHI
- SEC 8-K filings only: https://www.quantisnow.com/company/CPHI/8-k
- RSS and alerts for CPHI: https://www.quantisnow.com/docs/rss-feeds.md
